Cencora stock slides 1.10% and underperforms competitors
Updated
Updated · MarketWatch · Apr 30
Cencora stock slides 1.10% and underperforms competitors
8 articles · Updated · MarketWatch · Apr 30
Shares closed at $308.01 on Thursday, their second straight loss, as the S&P 500 rose 1.02% and the Dow gained 1.62%.
Cencora finished 18.42% below its 52-week high of $377.54 reached on 25 November, while Amazon rose 0.77%, UnitedHealth slipped 0.07% and CVS fell 0.73%.
Trading volume reached 2.1 million shares, above the stock's 50-day average of 1.3 million, indicating heavier activity during the decline.
With conflicting analyst ratings, will Cencora's multi-billion dollar acquisitions deliver growth or just higher debt?
As 100% tariffs threaten drug imports, can Cencora's supply chain pivot fast enough to prevent shortages?